<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Copyright &#239;&#8250;&#8482; 2002 Genetics Society America <br />  <br />  <br />  <br />           IBD2 Encodes Novel Component Bub2p-Dependent Spindle <br />                Checkpoint Budding Yeast Saccharomyces cerevisiae <br />  <br />                                                 Hyung-Seo Hwang Kiwon Song1 <br />                              Department Biochemistry, College Science, Yonsei University, Seoul 120-749, Korea <br />                                                       Manuscript received November 30, 2001 <br />                                                       Accepted publication March 25, 2002 <br />  <br />  <br />                                                               ABSTRACT <br />                 mitosis, genomic integrity maintained proper coordination mitotic events              spindle checkpoint. bifurcated spindle checkpoint blocks cell cycle progression metaphase              monitoring unattached kinetochores inhibits mitotic exit response incorrect orientation              mitotic spindle. Bfa1p spindle checkpoint regulator budding yeast Bub2p checkpoint <br />              pathway proper mitotic exit. isolated novel Bfa1p interacting protein named Ibd2p              budding yeast Saccharomyces cerevisiae. IBD2 (Inhibition Bud Division 2) essential <br />              gene deletion mutant proceeded cell cycle presence microtubule-destabilizing <br />              drugs, inducing sharp decrease viability. addition, overexpression Mps1p caused partial <br />              mitotic arrest ibd2&#226;&#338;&#172; bub2&#226;&#338;&#172;, suggesting IBD2 encodes novel component spindle <br />              checkpoint downstream MPS1. Overexpression Ibd2p induced mitotic arrest increased levels <br />              Clb2p wild type mad2&#226;&#338;&#172;, deletion mutants BUB2 BFA1. Pds1p stabilized <br />              overexpression Ibd2p wild-type cells. mitotic arrest defects observed ibd2&#226;&#338;&#172;              presence nocodazole restored additional copies BUB2, BFA1, CDC5, extra <br />              copy IBD2 rescue mitotic arrest defects bub2&#226;&#338;&#172; bfa1&#226;&#338;&#172;. mitotic arrest defects              ibd2&#226;&#338;&#172; recovered MAD2, vice versa. Analysis double mutant combinations ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172;, <br />              ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172;, ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172; showed IBD2 belongs BUB2 epistasis group. Taken               data demonstrate IBD2 encodes novel component BUB2-dependent spindle checkpoint <br />              pathway functions upstream BUB2 BFA1. <br />  <br />  <br />  <br /> C    ELLS ensure genomic integrity division <br />       checkpoints control cell cycle pro- <br /> gressions monitoring successful completion                                                                             dle checkpoint absence spindle damage <br />                                                                             wild-type cells spindle checkpoint <br />                                                                             mutants, placing MPS1 upstream spindle check- <br /> preceding processes. mitotic checkpoint, known                          point genes (Hardwick et al. 1996). spindle check- spindle checkpoint, monitors assembly                        point bifurcates separate signaling pathways, <br /> orientation mitotic spindle equal segrega-                   MAD/BUB spindle assembly checkpoint meta- <br /> tion replicated chromosomes mitosis. sens-                     phase arrest BUB2-dependent pathway block <br /> ing defects microtubule cytoskeleton, spindle                    mitotic exit cytokinesis (Alexandru et al. 1999; Li <br /> checkpoint arrests cells metaphase prevents exit                     1999). mitosis regulation Cdk activity.                           Bub1p, Bub3p, Mad1p, Mad2p, Mad3p form spindle checkpoint vital maintaining genomic                     conserved spindle assembly checkpoint monitors <br /> stability cell division, deficiency                      attachment bipolar microtubules kineto- <br /> checkpoint lead genomic instability associated                       chores sister chromatids delays metaphase- cancer (Cahill et al. 1998). Genetic studies                        anaphase transition response spindle assembly <br /> budding yeast identified components                         defects inhibiting Cdc20p (Fang et al. 1998; Hwang spindle checkpoint isolating mutants                      et al. 1998). Cdc20p key component anaphase- longer sense spindle depolymerization died rap-                      promoting complex (APC) targets B-type cyclin <br /> idly presence microtubule-depolymerizing                          Clb5p anaphase inhibitor Pds1p degrada- <br /> drugs nocodazole benomyl (Hoyt et al. 1991;                      tion ubiquitin-mediated proteolysis trigger chro- <br /> Li Murray 1991). components include                               mosome separation anaphase onset (Zachariae et <br /> MAD1, MAD2, MAD3, BUB1, BUB2, BUB3, MPS1.                               al. 1998; Shirayama et al. 1999). Homologs yeast <br /> Overexpression MPS1 sufficient activate spin-                  Mad1p, Mad2p, Bub1p, Bub3p identified <br />                                                                             localized unattached kinetochores higher eu- <br />                                                                             karyotes, including mammalian cells (Chen et al. 1996, <br />   1 <br />                                                                             1998; Taylor McLeon 1997; Taylor et al. 1998; <br />    Corresponding author: Department Biochemistry, College Sci- <br /> ence, Yonsei University, Seoul 120-749, Korea.                              Martinez-Exposito et al. 1999), mecha- <br /> E-mail: bc5012@yonsei.ac.kr                                                 nism senses spindle defects understood. <br /> Genetics 161: 595&#226;&#8364;&#8220;609 ( June 2002) <br />  596                                                   H.-S. Hwang K. Song <br />  <br /> Vertebrate homologs Cdc20p Pds1p                   cells treated 15 &#226;?&#174;g/ml nocodazole 0, 3, 6 hr, identified, suggesting spindle assembly check-            respectively, plated YPD nocodazole,                                                                     percentage viability time point calculated point mechanisms conserved eukaryotes                   dividing number colonies formed 0, 3, 6 hr (Zou et al. 1999).                                                  number time 0 (Straight Murray 1997).    Bub2p present spindle pole body, micro-            plate assays, equivalent numbers cells grown YPD tubule-organizing center yeast, forms separate             OD600 1.0 serially diluted, spotted YPD (&#226;&#171;&#186;) <br /> branch spindle checkpoint pathway controls              benomyl YPD (&#226;&#171;&#185;) benomyl (10 &#226;?&#174;g/ml) plates, incu- <br />                                                                     bated 25&#226;&#172;&#353; 3&#226;&#8364;&#8220;4 days. assay cell cycle progression, cells <br /> mitotic exit timing cytokinesis (Fesquet et              extra new bud(s) counted cells arrested <br /> al. 1999; Fraschini et al. 1999; Li 1999). fission           &#226;?&#163;-factor released presence nocodazole <br /> yeast Schizosaccharomyces pombe, Bub2p homolog                  (15 &#226;?&#174;g/ml) 3 hr. counting, cells time <br /> Cdc16p interacts Byr4p form component                 point briefly fixed 70% ethanol sonicated lightly. <br /> GTPase activating protein (GAP) stimulates                    Yeast hybrid screen: Yeast hybrid screening  <br />                                                                     formed essentially following Gyuris et al. (1993).  <br /> GTPase activity Spg1p coordinate onset                 length BFA1 subcloned pLex202 &#226;&#171;&#185; PL used cytokinesis (Furge et al. 1998; Jwa Song 1998).                 bait screen. interactor hunt, EGY48 BFA1/ <br /> BFA1, putative byr4 homolog budding yeast             pLex202 &#226;&#171;&#185; PL transformed cDNA library pJG4-5, known IBD1 BYR4, reported                 expression cloned cDNA function BUB2-dependent spindle checkpoint                control GAL1-inducible promoter. total 50,000 colo- <br />                                                                     nies screened. True positive interaction verified mitotic exit cytokinesis (Alexandru et al. 1999;            leucine assay EGY48, chromosomal LEU2 replaced <br /> Lee et al. 1999; Li 1999). simplest model budding            LexAop6-LEU2. True positives grew SC-leu dropout <br /> yeast Bub2p Bfa1p form              media presence galactose/raffinose GAP activity inhibits Tem1p prevent cells            glucose, cDNA expressed galactose/raffinose <br /> exiting mitosis, checkpoint activated.                confirm interaction Ibd2p Bfa1p, <br />                                                                     length IBD2 open reading frame (ORF) subcloned <br /> cently Bub2p checkpoint, including Bub2p, Bfa1p,                pJG4-5 hybrid assay performed BFA1. Tem1p, shown monitor spindle orienta-                  DNA manipulations strain constructions: BFA1 <br /> tion anaphase inhibit mitotic exit               ORF amplified PCR genomic DNA 5&#226;&#172;&#732; <br /> nuclear migration bud delayed (Bardin et                oligonucleotide 5&#226;&#172;&#732;-TTGGATCCCTATGTCAATTAG-3&#226;&#172;&#732; al. 2000; Bloecher et al. 2000; Pereira et al. 2000).               3&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-CAATGGATCCGGCTAAAGGGCTAAT <br />                                                                     CTTTTG-3&#226;&#172;&#732; subcloned BamHI site pLex202 &#226;&#171;&#185; <br /> Mitotic exit ultimately repressed inhibiting Cdh1p/           PL used bait hybrid screening. express <br /> Hct1p, targets degradation mitotic cyclin              hemagglutinin (HA)-tagged BFA1 CEN plasmid Clb2p APC (Schwab et al. 1997; Visintin                 endogenous promoter, promoter ORF BFA1 <br /> et al. 1997; Zachariae et al. 1998).                                amplified 5&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-TGCTCTAGAC <br />    study, discuss function IBD2,            GGAGCAAGAGATAGTCTGAG-3&#226;&#172;&#732; containing XbaI site                                                                     3&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-ACAGGATCCATCTTTTGTCGAAT isolated basis interaction BFA1                                                                     TGATTACCATGTT-3&#226;&#172;&#732; containing BamHI site sub- <br /> budding yeast, present evidence IBD2 plays               cloned pTS903CL  gift Dr. Toh-e, Tokyo Univer- <br /> role spindle checkpoint pathway belongs               sity). ORF IBD2 amplified PCR genomic BUB2 epistasis group.                                           DNA 5&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-GGGTTTATATGAATC <br />                                                                     ATAGACTAATATAG-3&#226;&#172;&#732; 3&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-CCTG <br />                                                                     TTACTATTTAGTCATAATACCGC-3&#226;&#172;&#732; subcloned                MATERIALS METHODS                                SpeI SacI sites pRS316 pRS315 T-vector <br />                                                                     (Promega, Madison, WI). ORF IBD2 sub- <br />    Yeast strains, cultures, cell cycle arrest, release:     cloned pJG4-5 amplifying 5&#226;&#172;&#732; oligonucleotide <br /> Saccharomyces cerevisiae strains used study listed   5&#226;&#172;&#732;-CCGGAATTCAAGAAAATGACACCTACAAACC-3&#226;&#172;&#732; containing <br /> Table 1. Yeast cells grown YPD medium (1% yeast             EcoRI site 3&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-TTCCTCGAGTA <br /> extract, 2% bactopeptone, 2% glucose) synthetic           ATAATGTTGACTATCTATTC-3&#226;&#172;&#732; containing XhoI site. complete (SC) dropout media prepared yeast nitrogen            overexpression IBD2 GAL10-1 promoter, base (YNB) necessary supplements. induce expressions         ORF IBD2 amplified 5&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;- GAL10-1 GAL1 promoter, cells grown midlog            ATCGAATTCAAAATGACACCTACAAACCAATC-3&#226;&#172;&#732; containing <br /> phase 2% glucose transferred SC dropout media            EcoRI site 3&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-TAAGGATCCC raffinose 4 hr, 2% galactose added culture,    TATCTATTCCTTTTCC-3&#226;&#172;&#732; containing BamHI site sub- cells incubated 2% raffinose/galactose         cloned pMW20. <br /> 12&#226;&#8364;&#8220;14 hr 29&#226;&#172;&#353;. Cell cycles log phase cells (5 &#226;&#171;&#187; 106 cells/        make YSK1 strain IBD2 ORF tagged ml) arrested final concentration 6 &#226;?&#174;m &#226;?&#163;-factor       Myc 3&#226;&#172;&#732; end integrated chromosome <br /> (Sigma, St. Louis) 0.1 m hydroxyurea (HU; Sigma) 3           IBD2 knockout strain (CDLY011), length ORF <br /> hr released cell cycle arrest washing cultures      IBD2 amplified 5&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-TATCTG fresh medium times.                                      CAGCATAGACTAATATAGATAG-3&#226;&#172;&#732; 3&#226;&#172;&#732; oligonucleo- <br />    Assays sensitivity microtubule-destabilizing drugs:   tide 5&#226;&#172;&#732;-ACTCTGCAGTTCATCTCTTGGTGGATTC-3&#226;&#172;&#732; sub- <br /> nocodazole treatment, cells grown midlog phase (5 &#226;&#171;&#187;         cloned PstI site pTS905IT  gift Dr. Toh-e, <br /> 106 cells/ml) YPD 29&#226;&#172;&#353; nocodazole added           Tokyo University). IBD2-Myc pTS905IT linearized <br /> final concentration 15 &#226;?&#174;g/ml 10 mg/ml stock            EcoRI, transformed CDLY012 (ibd2&#226;&#338;&#172;), selected <br /> DMSO. Cells incubated 25&#226;&#172;&#353; presence nocoda-        SC-trp plates. YSK2, YSK3  ibd2&#226;&#338;&#172;), YSK5 (ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172;), <br /> zole, specified. assay viability, number      YSK7 (ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172;), YSK9 (ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172;), YSK10 (ibd2&#226;&#338;&#172; <br />                               IBD2 Encodes Novel Spindle Checkpoint Regulator Budding Yeast                                  597 <br />  <br />                                                                TABLE 1 <br />                                                      Yeast strains used study <br />  <br />          Strain                                          Genotype                                          Source <br />          W303               MATa ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15 <br />          FY1679C            MATa ura3-52 leu2-1 his3/MAT&#226;?&#163; ura3-52 leu2-1 his3                                F. Galibert <br />          EGY48              MATa LEU2::LexAop6-LEU2 ura3 his3 trp1 GAL&#226;&#171;&#185;                                      J. Kim <br />          CDLY011            MATa IBD2::KanMX4 ura3-52 leu2-3 112 trp1-289 his3-1                             C. Rodriquez <br />          CDLY012            MAT&#226;?&#163; IBD2::KanMX4 ura3-52 3-200 trp1-63                                      C. Rodriquez <br />          FY1674             MATa BFA1::KanMX4 ura3-52 leu2&#226;&#338;&#172;1 his3                                            F. Galibert <br />          RHC 15.1           MATa MAD2::URA3 ura3-1 leu2,3-112 his3-11 trp1-1 ade2-1 can1-100                 R-H. Chen <br />          MAY2052            MAT&#226;?&#163; BUB2::URA3 lys2-801 his3-&#226;&#338;&#172;200 leu2-3,112 ura3-52 GAL&#226;&#171;&#185;                        Hoyt <br />          KT1374             MATa DYN1::HIS3 leu2 ura3-52 his3                                                K. Tatchell <br />          YSK1               MAT&#226;?&#163; IBD2::KanMX4 IBD2-Myc, TRP ura3-52 3-200 trp1-63                    study <br />          YSK2               MATa IBD2::URA3 ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15                       study <br />          YSK3               MATa IBD2::HIS3 ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15                       study <br />          YSK4               MAT&#226;?&#163; IBD2::KanMX4 BUB2::URA3                                                     study <br />          YSK5               MATa IBD2::HIS3 BUB2::URA3 ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15            study <br />          YSK6               MATa IBD2::KanMX4 MAD2::URA3                                                     study <br />          YSK7               MATa IBD2::HIS3 MAD2::URA3 ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15            study <br />          YSK8               MATa BFA1::HIS3 ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15                       K. Song <br />          YSK9               MATa IBD2::HIS3 DYN1::URA3                                                       study <br />          YSK10              MATa IBD2::HIS3 ura3-52 leu2&#226;&#338;&#172;1 his3 BFA1::KanMX4                                 study <br />          YSK11              MATa BUB2::TRP1 ura3-1 trp1-1 ade2-1 leu2-3,112 his3-11,15                       study <br />  <br />  <br />  <br /> bfa1&#226;&#338;&#172;) constructed PCR-based gene deletion (Wach             62.5 mm &#226;?&#164;-mercaptoethanol 90 min 30&#226;&#172;&#353;. Microtubules <br /> et al. 1994; Longtine et al. 1998) using 5&#226;&#172;&#732; 3&#226;&#172;&#732; primers      stained 1:100 diluted anti-&#226;?&#163;-tubulin mouse mono- <br /> contained 50 nucleotides spanning start stop codons           clonal antibody (Sigma) followed 1:50 diluted Texas red- targeted genes, respectively. YSK2, URA3             conjugated anti-mouse IgG (Molecular Probes, Eugene,  <br /> pRS316 amplified 5&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-CAA              mounted DAPI. microscopy, cells GAAAATGACACCTACAAACCAATCTAGTGGAACGACTAA                              observed &#226;&#171;&#187;100 objective Zeiss (Thornwood, NY) <br /> TGCATCTGTGGAGGTACGTACTGAGAGTGCACCACGC-3&#226;&#172;&#732;                             Axioskop Leica (Deerfield,  fluorescence DMR. 3&#226;&#172;&#732; oligonucleotide 5&#226;&#172;&#732;-GACTATCTATTCCTTTTCC                    Photographs taken Tmax 400 film negatives <br /> TACTATCTTGTTCATCTCTTGGTGGATTCGGCATACGC                               scanned Proimager 8200 (Pixelcraft) figures, <br /> TCCTTACGCATCTGTGCGG-3&#226;&#172;&#732;. YSK3, HIS3 pRS303                   alternatively images taken directly using Leica DC200 amplified 5&#226;&#172;&#732;-GAAGAAAATGACACCTACAAACCAA                      Leica DC viewer. <br /> TCTAGTGGAACGACTAATGCATCTGAGCTTGGTGAGCG                                  Fluorescence-activated cell sorter analysis: flow cytome- <br /> CTAGGAGTCAC-3&#226;&#172;&#732; 5&#226;&#172;&#732;-GACTATCTATTCCTTTTCCTAC                         try, budding yeast cells prepared essentially described <br /> TATCTTGTTCATCTCTTGGTGGATTCGGCTCGTTCAGAA                              Paulovich Hartwell (1995). Briefly, cells fixed <br /> TGACACGTATAG-3&#226;&#172;&#732;. PCR products transformed                  70% ethanol overnight 4&#226;&#172;&#353; washed 50 mm sodium <br /> W303, selected using URA3 HIS3 markers, verified             citrate (pH 7.5). total 4 &#226;&#171;&#187; 106 cells resuspended genomic PCR Southern blotting. PCR prod-             0.5 ml 50 mm sodium citrate incubated 250 &#226;?&#174;g/ <br /> uct used construct YSK3 transformed MAY2052         ml RNase followed 1 mg/ml proteinase K 1 hr 50&#226;&#172;&#353;, <br /> (bub2&#226;&#338;&#172;), RHC 15.1 (mad2&#226;&#338;&#172;), KT1374 (dyn1&#226;&#338;&#172;), YSK8                  respectively. adding 0.5 ml propidium iodide 50 mm <br /> (bfa1&#226;&#338;&#172;) construct YSK5 (ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172;), YSK7 (ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172;),           sodium citrate (final concentration 8 &#226;?&#174;g/ml), samples YSK9 (ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172;), YSK10 (ibd2&#226;&#338;&#172;bfa1&#226;&#338;&#172;), respectively.             incubated dark 12&#226;&#8364;&#8220;24 hr 4&#226;&#172;&#353; sonicated <br /> YSK4 (ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172;) YSK6 (ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172;) essen-             briefly just fluorescence-activated cell sorter (FACS) <br /> tially following Sena et al. (1973). Diploids constructed    analysis. sample, 20,000 cells analyzed mating CDLY011 (ibd2&#226;&#338;&#172;) MAY2052 (bub2&#226;&#338;&#172;) CDLY012             Becton Dickinson (San Jose, CA) fluorescence-activated cell <br /> (ibd2&#226;&#338;&#172;) RHC 15.1 (mad2&#226;&#338;&#172;) opposite mating types             analyzer. standard DNA content FACS surface agar plates sporulated sporulation        analysis, &#226;?&#163;-factor-treated haploid wild-type (W303) cells [G1 <br /> plates 25&#226;&#172;&#353; 6&#226;&#8364;&#8220;7 days. Tetrads resuspended 1 ml         (1N)], wild-type cells log phase [G1 (1N) G2 (2N)], <br /> ddH2O, incubated 0.25 mg zymolase 20T (Seikagaku,               wild-type diploid (FY1679C) cells log phase (2N Rockville, MD) overnight 30&#226;&#172;&#353; gentle shaking, sonicated       4N) used. <br /> briefly, spread YPD. genotype spore colony           Coprecipitation immunoblot: detect coprecipita- determined replica plating selective media.                tion Bfa1p/Ibd1p Ibd2p, YSK1 cells transformed    Microscopic techniques: observe nuclei cell shape,         BFA1-HA/pTS903CL grown 5 &#226;&#171;&#187; 106 cells/ml cells fixed 70% ethanol 5 sec, washed twice         proteins extracted H-buffer [25 mm Tris-HCl pH 7.4, <br /> PBS, briefly sonicated, mounted 1 &#226;?&#174;g/ml 4&#226;&#172;&#732;,6-diami-         15 mm EGTA pH 7.5, 15 mm MgCl2, 0.1% Triton X-100, 10% <br /> dino-2-phenylindole (DAPI). immunostaining, cells           glycerol, 1 mm NaN3, 0.6 mm sodium vanadate pH 7.0, 1&#226;&#171;&#187; <br /> fixed incubating 3.7% <span id='am-16' about='obo:IMR_0200017' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-17' property="rdfs:label" content="Formaldehyde" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:id" content="IMR:0200017" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasDbXref" content="KEGG:C00067" datatype="xsd:string"></span>formaldehyde</span> 2 hr, washed            protease cocktail DMSO (Boehringer Mannheim, Indianap- KPO4 (pH 6.5) twice, resuspended KPO4 (pH 6.5)           olis), 1 mm dithiothreitol, 5 mg/ml phenylmethylsulfonyl <br /> containing 1.2 m sorbitol. Fixed cells permeabilized       fluoride] beadbeating (Mark et al. 1990). cell lysate final concentration 300 &#226;?&#174;g/ml zymolase (Seikagaku)          incubated anti-HA antibody (Novagen) 2 hr fol- <br />  598                                                H.-S. Hwang K. Song <br />  <br /> lowed Protein Sepharose (Sigma) 1 hr 4&#226;&#172;&#353;, Protein Sepharose washed twice H-buffer. SDS <br /> sample buffer (6&#226;&#171;&#187;) added resin, resin boiled 5 min, proteins resolved using 10% <br /> SDS-PAGE. resolved proteins transferred nitro- <br /> cellulose membrane incubated polyclonal rab- <br /> bit anti-HA antisera polyclonal mouse anti-Myc antisera <br /> (Upstate Laboratories), respectively. Bound antibodies detected anti-rabbit anti-mouse IgG-HRP ( Jackson Im- <br /> munochemicals, West Grove, PA) enhanced chemilumi- <br /> nescence (ECL) reagents (Amersham, Arlington Heights, . <br />    immunoblots, cell extracts prepared described protein concentration yeast extract deter- <br /> mined dye-binding assay (Pierce, Rockford, ). total 35 &#226;?&#174;g total protein extract separated 8% SDS-PAGE, transferred membrane, incubated polyclonal goat anti-Clb2 antisera (Santa Cruz Biotech- <br /> nology), polyclonal rabbit anti-Pds1 antisera (Santa Cruz Bio- <br /> technology), monoclonal rabbit anti-actin antisera (Calbio- <br /> chem-Novabiochem, La Jolla, CA) followed anti-goat anti-rabbit IgG-HRP detected ECL. <br />  <br />  <br />                          RESULTS <br />  <br />    IBD2 isolated interaction BFA1 bud- <br /> ding yeast: Loss BFA1 results reduced viability presence microtubule-destabilizing drugs, dem- <br /> onstrating function spindle checkpoint bud- <br /> ding yeast (Alexandru et al. 1999; Li 1999). identify <br /> new components BFA1-dependent spindle check-                Figure 1.&#226;&#8364;&#8221; Ibd2p isolated Bfa1p-interacting pro- <br /> point, performed yeast hybrid screen. open           tein yeast hybrid screen.   Ibd2p directly interacts <br /> reading frame YNL164C encodes potential Bfa1p             Bfa1p yeast hybrid assay. specific positive <br />                                                                  interaction Ibd2p Bfa1p verified LEU assay <br /> interacting protein isolated, named IBD2            true positives grow galactose/raffinose <br /> (Inhibition Bud Division 2) basis overex-       SC-ura,  leu, trp (left) glucose SC-ura,  leu, <br /> pression phenotypes described  Ibd2p exhibited             trp (right), expression IBD2 cDNA specific interactions Bfa1p yeast hybrid         control GAL1 promoter. Lanes 1 2 positive <br /> LEU assay, IBD2 GAL1 promoter                 negative controls, respectively. Lane 3 shows specific <br />                                                                  interaction Ibd2p Bfa1p, bait screen, SC <br /> interacted BFA1 expression             gal/raff-ura,  leu, trp SC glu-ura,  leu, trp. <br /> duced galactose/raffinose (Figure 1A). verify          (B) Ibd2p coprecipitates Bfa1p. Strain YSK1, direct interaction Bfa1p Ibd2p, constructed            IBD2 tagged Myc integrated chromo- <br /> strain YSK1 IBD2 tagged Myc             ibd2&#226;&#338;&#172;, transformed low copy plasmid car- C terminus integrated chromosome             rying BFA1-HA (pTS903CL/BFA1-HA), Myc-tagged Ibd2p <br />                                                                  HA-tagged Bfa1p coexpressed endoge- <br /> ibd2&#226;&#338;&#172; expressed endogenous pro-                nous promoters (lane 2). Wild-type cells transformed <br /> moter. YSK1 wild-type cells transformed            low copy plasmid carrying BFA1-HA (pTS903CL/BFA1- low copy plasmid carrying BFA1-HA endoge-            HA; lane 1). Strain YSK1 transformed pTS903CL <br /> nous promoter. HA-tagged Bfa1p purified                 vector negative control (lane 3). HA-tagged Bfa1p anti-HA antibody, HA-tagged Bfa1p exclusively            purified anti-HA antibody Protein Sepharose. <br />                                                                  Lane 2 shows HA-tagged Bfa1p exclusively coprecipitated <br /> precipitated Myc-tagged Ibd2p expressed YSK1             Myc-tagged Ibd2p. Lane 1 shows Ibd2p wild type <br /> (Figure 1B).                                                     detected anti-Myc lane 3 shows Myc- <br />    verified expression IBD2 S. cerevisiae        tagged Ibd2p pTS903CL vector did interact. Northern blot (data shown). IBD2 encodes protein           purified HA-tagged Bfa1p detected predicted contain 352 amino acids. BLASTP search            immunoblotting anti-HA antibody Myc-tagged Ibd2p <br />                                                                  detected anti-Myc antibody, respectively. (C) pre- sequences GenBank using length Ibd2p              dicted protein structure Ibd2p containing motif sequence revealed meaningful similarity, motif          CCPHHHYENLS amino acids 262 273 search showed Ibd2p contains conserved se-                frequently chitinase families e-MOTIF database <br /> quence amino acids 263 273 (CCPHHHY-                 search. Boldface letters indicate amino acids conserved  <br />                                                                  tween Ibd2p proteins motif. <br /> ENLS) chitinase families (Figure 1C) <br /> (Huang Brutlag 2001). similar motif BIK1 DFG10, shown Figure 1C <br /> (Berlin et al. 1990; Mosch Fink 1997). <br />                               IBD2 Encodes Novel Spindle Checkpoint Regulator Budding Yeast                          599 <br />  <br />                                                                    ml benomyl exhibited similar degree hypersensitiv- <br />                                                                    ity mad2&#226;&#338;&#172;, bub2&#226;&#338;&#172;, bfa1&#226;&#338;&#172; cells. experiments <br />                                                                    described Figures 2&#226;&#8364;&#8220;5, used spindle checkpoint <br />                                                                    mutants isogenic W303 background bub2&#226;&#338;&#172;. <br />                                                                    bub2&#226;&#338;&#172; W303 (YSK11) confirmed <br />                                                                    obvious difference physiological  <br />                                                                    sponses bub2&#226;&#338;&#172; strains different  <br />                                                                    grounds. <br />                                                                       phenotype spindle checkpoint-defective <br />                                                                    mutants repeated budding mitotic arrest                                                                    presence microtubule-destabilizing drugs.  <br />                                                                    vestigate hypersensitivity ibd2&#226;&#338;&#172; cells                                                                    nocodazole inability arrest cell <br />                                                                    cycle mitosis, examined rebudding counting <br />                                                                    cells formed new bud mitotic spindle forma- <br />                                                                    tion inhibited nocodazole. ibd2&#226;&#338;&#172; cells arrested <br />                                                                    G1 &#226;?&#163;-factor released presence 15 <br />                                                                    &#226;?&#174;g/ml nocodazole number cells                                                                    bud compared wild-type                                                                    spindle checkpoint mutant cells. number                                                                    cells new bud changed wild-type <br />                                                                    cells (W303), increased ibd2&#226;&#338;&#172;                                                                    mad2&#226;&#338;&#172;, bub2&#226;&#338;&#172;, bfa1&#226;&#338;&#172; cells (Figure 3A). <br />                                                                       compared microscopy phenotypes                                                                    ibd2&#226;&#338;&#172; cells wild type hour 6 hr, <br />                                                                    cells arrested &#226;?&#163;-factor released 15 &#226;?&#174;g/ <br />    Figure 2. deletion mutant IBD2 sensitive mi-       ml nocodazole. Wild-type cells progressed crotubule-destabilizing drugs.   Viability IBD2 dele-     cell cycle mitosis, time arrested tion mutant cells decreases sharply presence nocoda-     large bud condensed nucleus bud neck <br /> zole. Wild-type (W303), bfa1&#226;&#338;&#172; (YSK8), ibd2&#226;&#338;&#172; (YSK2), &#226;&#338;&#172;bub2          (Figure 3B, right). ibd2&#226;&#338;&#172; cells enlarged <br /> (MAY2052), mad2&#226;&#338;&#172; (RHC 15.1) cells grown mid- <br /> log phase (5 &#226;&#171;&#187; 106 cells/ml), incubated 15 &#226;?&#174;g/ml nocoda- <br />                                                                    2 hr compared wild type (suggesting transient <br /> zole 0, 3, 6 hr, respectively, plated YPD   mitotic delay), produced aberrant extra bud(s) nocodazole measure viability. percentage viable      3 hr presence nocodazole (Figure 3B, <br /> cells (%) calculated relative number viable cells    . Transient mitotic delay similar enlarged time 0. independent experiments performed            phenotypes observed deletion mutants average plotted standard deviations. (B) <br /> ibd2&#226;&#338;&#172; cells sensitive benomyl plate assays. Actively <br />                                                                    BUB2 BFA1 treated microtubule-destabiliz- <br /> growing wild-type (W303), bfa1&#226;&#338;&#172; (YSK8), ibd2&#226;&#338;&#172; (YSK2), bub2&#226;&#338;&#172;        ing drugs (Hoyt et al. 1991; Fesquet et al. 1999; Li 1999; <br /> (MAY2052), mad2&#226;&#338;&#172; (RHC 15.1) cells serially diluted        data shown). transient enlarged phenotype <br /> 10-fold spotted YPD plates (left) YPD plates    observed ibd2&#226;&#338;&#172; bub2&#226;&#338;&#172; bfa1&#226;&#338;&#172; mutants <br /> containing 10 &#226;?&#174;g/ml benomyl (right).                               following exposure nocodazole explained <br />                                                                    temporary mitotic arrest presence                                                                    functional MAD2 spindle assembly checkpoint pathway. <br />    IBD2 encodes component spindle checkpoint:             nocodazole-treated ibd2&#226;&#338;&#172; cells, nucleus deletion IBD2 lethal showed                  failed properly divided mother <br /> growth defects, case BFA1 deletion          bud(s) (Figure 3B, . observations <br /> mutant (Duenas et al. 1999; data shown). deter-             ibd2&#226;&#338;&#172; cells ultimately arrest cell Ibd2p functions spindle check-                 cycle mitosis progressed cell cycle <br /> point, tested sensitivity ibd2&#226;&#338;&#172; cells suble-        proper nuclear division cytokinesis,  <br /> thal concentration nocodazole. incubation            ported spindle checkpoint mutants including <br /> 15 &#226;?&#174;g/ml nocodazole, viability ibd2&#226;&#338;&#172; cells               mad2&#226;&#338;&#172;, bub2&#226;&#338;&#172;, bfa1&#226;&#338;&#172; (Hoyt et al. 1991; Fesquet et <br /> creased sharply mad2&#226;&#338;&#172;, bub2&#226;&#338;&#172;, bfa1&#226;&#338;&#172;              al. 1999; Li 1999), microtubule-destabilizing <br /> cells (Figure 2A). reported, mad2&#226;&#338;&#172; cells              drugs inhibited mitotic spindle formation. <br /> sensitive drug bub2&#226;&#338;&#172; cells (Fesquet et               verify ibd2&#226;&#338;&#172; mutant progressed al. 1999). confirm results, sensitivity            cell cycle presence mitotic spindle defects <br /> ibd2&#226;&#338;&#172; cells benomyl examined conventional                spindle checkpoint mutants, ibd2&#226;&#338;&#172; cells ar- <br /> plating experiments. plate assay shown Figure            rested &#226;?&#163;-factor released cell cycle arrest <br /> 2B, ibd2&#226;&#338;&#172; cells serially diluted presence 10 &#226;?&#174;g/         medium containing nocodazole 3 hr,  600   H.-S. Hwang K. Song <br />                              IBD2 Encodes Novel Spindle Checkpoint Regulator Budding Yeast                                 601 <br />  <br /> DNA contents analyzed flow cytometry. Wild-                 netics wild type, Clb2p began degrade 100 <br /> type, ibd2&#226;&#338;&#172;, bub2&#226;&#338;&#172;, bfa1&#226;&#338;&#172;, mad2&#226;&#338;&#172; cells contained            min, completely degraded 120 min, started G1 (1N) G2 (2N) DNA content                    reaccumulate 140 min (Figure 3D). observed <br /> absence nocodazole (Figure 3C, left).                  profile Clb2p ibd2&#226;&#338;&#172; cells consistent larger proportion ibd2&#226;&#338;&#172;, bub2&#226;&#338;&#172;, bfa1&#226;&#338;&#172; cells              results ibd2&#226;&#338;&#172; cells exited mitosis pro- <br /> tained G2 (2N) DNA content compared wild type,                 gressed cell cycle presence noco- <br /> suggesting possible delay mitosis (Figure 3C, left).           dazole. Taken  data demonstrate incubation nocodazole 3 hr, ibd2&#226;&#338;&#172;,               Ibd2p functions spindle checkpoint budding <br /> bub2&#226;&#338;&#172;, bfa1&#226;&#338;&#172;, mad2&#226;&#338;&#172; cells displayed G2 (2N)               yeast. higher DNA content, wild-type cells                  IBD2 functions downstream MPS1: ex- <br /> tained G2 (2N) DNA content (Figure 3C, right).               amine function IBD2 spindle checkpoint DNA content ibd2&#226;&#338;&#172; cells presence                   pathway, MPS1 overexpression phenotypes ibd2&#226;&#338;&#172; mu- <br /> absence nocodazole similar observed             tants analyzed compared bub2&#226;&#338;&#172; bub2&#226;&#338;&#172; bfa1&#226;&#338;&#172;. distribution DNA content                mad2&#226;&#338;&#172; checkpoint mutants introducing plas- ibd2&#226;&#338;&#172; consistent new bud formation                  mid overexpressed Mps1p GAL1 pro- <br /> phenotypes described previously demonstrated               moter. Cells transformed plasmid vector ibd2&#226;&#338;&#172; cells proceeded cell cycle                used negative controls. shown previously, replicated DNA proper nuclear division                overexpression Mps1p sufficient cause cytokinesis despite loss mitotic spindle.              mitotic delay activating MAD- BUB-depen- characteristics reported spindle           dent spindle checkpoints absence spindle dam- <br /> checkpoint mutants including mad2&#226;&#338;&#172;, bub2&#226;&#338;&#172;, bfa1&#226;&#338;&#172;                age, locating MPS1 upstream checkpoint com- <br /> (Hoyt et al. 1991; Fesquet et al. 1999; Li 1999).                   posed genes (Hardwick et al. 1996).  <br />    exposed microtubule-destabilizing drugs                  arguable Mps1p overexpression affects nocodazole, wild-type yeast cells arrest mitosis         bifurcated spindle checkpoint pathways stabilization B-type cyclins ele-            MAD/BUB pathway BUB2-dependent <br /> vated activity cyclin B-associated Cdc28 kinase.            pathway, observed mitotic delay Mps1p level Clb2 protein serves excellent marker             overexpression completely eliminated mad2&#226;&#338;&#172; mitotic arrest. assess cell cycle progression        bub2&#226;&#338;&#172; mutants (Alexandru et al. 1999; Fesquet ibd2&#226;&#338;&#172; cells, compared Clb2 protein levels ibd2&#226;&#338;&#172;            et al. 1999; Li 1999). displayed Table 2, Mps1p wild-type cells incubated nocodazole. Cells syn-           overexpression galactose-containing media 12 hr <br /> chronized G1 &#226;?&#163;-factor released fresh                resulted mitotic arrest 76% wild-type cells, medium nocodazole collected 20 min                   19% cells negative control 140 min investigate level Clb2p.              mitotic stage. mitotic delay Mps1p overexpres- <br /> centage cells large bud nucleus            sion abolished mad2&#226;&#338;&#172;, compared neck counted sample index                mad2&#226;&#338;&#172; negative control (Table 2). Overexpression mitosis (Figure 3D, . Wild-type cells gradually accu-           Mps1p ibd2&#226;&#338;&#172; bub2&#226;&#338;&#172; caused mitotic delay, <br /> mulated maintained Clb2p high levels                  delay ibd2&#226;&#338;&#172; bub2&#226;&#338;&#172; presence nocodazole, cells arrested                wild type mad2&#226;&#338;&#172; (Table 2). mitosis. ibd2&#226;&#338;&#172; cells accumulated Clb2p similar ki-             similar percentage ibd2&#226;&#338;&#172; bub2&#226;&#338;&#172; mutant cells  <br />  <br />  <br />    Figure 3.&#226;&#8364;&#8221;IBD2 encodes component spindle checkpoint.   ibd2&#226;&#338;&#172; cells produce new bud presence nocodazole. Logarithmically growing wild-type (W303), bfa1&#226;&#338;&#172; (YSK8), ibd2&#226;&#338;&#172; (YSK2), bub2&#226;&#338;&#172; (MAY2052), mad2&#226;&#338;&#172; (RHC 15.1) <br /> cells arrested &#226;?&#163;-factor released presence 15 &#226;?&#174;g/ml nocodazole. number cells bud counted hour 3 hr fixation brief sonication. total 500 cells counted time point percentage cells bud calculated relative total counted cells. independent experiments performed average plotted standard deviations. (B) phenotypes ibd2&#226;&#338;&#172; cells presence nocodazole. Wild-type ibd2&#226;&#338;&#172; cells arrested &#226;?&#163;-factor released presence 15 &#226;?&#174;g/ml nocodazole 5 hr. <br /> Cells taken hour fixed, briefly sonicated, stained DAPI. shows wild-type cells incubated nocodazole (left) nocodazole 5 hr (right). shows phenotypes ibd2&#226;&#338;&#172; cells treated nocodazole hour depicted. panels scale. Bar, 5 &#226;?&#174;m. (C) ibd2&#226;&#338;&#172; cells progress subsequent cell cycle presence nocodazole. Wild-type (W303), ibd2&#226;&#338;&#172; (YSK2), bfa1&#226;&#338;&#172; (YSK8), bub2&#226;&#338;&#172; (MAY2052) cells arrested &#226;?&#163;-factor released cell cycle arrest presence nocodazole 3 hr DNA contents measured flow <br /> cytometry. Cells shown (left) nocodazole treatment (right). (D) ibd2&#226;&#338;&#172; cells accumulate Clb2p exposed microtubule-destabilizing drug. Wild-type (W303) ibd2&#226;&#338;&#172; (YSK2) cells arrested G1 &#226;?&#163;-factor released presence nocodazole 25&#226;&#172;&#353;. Cells collected 20 min 140 min cells grown large <br /> bud nucleus neck counted sample, shown graph. Cell extracts sample immunoblotted anti-Clb2 anti-actin antibody  loading control). <br />  602                                                H.-S. Hwang K. Song <br />  <br />  <br />  <br />  <br />    Figure 4. overexpression IBD2 induces mitotic arrest.   Cells overexpressing IBD2 arrested M phase. Wild- <br /> type (W303), bfa1&#226;&#338;&#172; (YSK8), bub2&#226;&#338;&#172; (MAY2052), mad2&#226;&#338;&#172; (RHC 15.1) cells transformed pMW20/IBD2 pMW20L/ <br /> IBD2 overexpression IBD2 GAL10-1 promoter induced 12 hr. Cells M phase counted fixation staining DAPI. strains transformed pMW20 used negative controls. average independent experiments shown standard deviation. (B) Cells overexpressing IBD2 mitotic spindle <br /> defects. mitotic spindle visualized immunostaining antitubulin cells overexpressing IBD2. cells M <br /> phase Ibd2p overexpression, number cells short mitotic spindle elongated spindle counted antitubulin staining displayed  section, shows cell metaphase short spindle displays cell elongated spindle. DNA (left) microtubule (right) staining shown. Bar, 5 &#226;?&#174;m. (C) <br /> Clb2p accumulates cells overexpressing IBD2. Cell extracts prepared (1) wild type (W303) transformed vector pMW20  (2) wild type cells IBD2 overexpression induced, (3) wild-type cells incubated nocodazole 3 hr. Extracts subjected immunoblottings using anti-Clb2p   anti-actin   loading <br /> control. (D) Clb2p does accumulate IBD2 overexpressed bfa1&#226;&#338;&#172; bub2&#226;&#338;&#172; mutant cells. IBD2 overexpression induced wild-type (W303), bfa1&#226;&#338;&#172; (YSK8), bub2&#226;&#338;&#172; (MAY2052), mad2&#226;&#338;&#172; (RHC 15.1) cells, Clb2p extracts sample analyzed immunoblotting using anti-Clb2p  . Actin shown loading control  . Lane 1, wild-type <br /> cells transformed vector control; lanes 2&#226;&#8364;&#8220;5, cells overexpressing Ibd2p [(2) wild type, (3) bfa1&#226;&#338;&#172;, (4) bub2&#226;&#338;&#172;, (5) mad2&#226;&#338;&#172;]. (E) Pds1p stabilized wild-type cells overexpressing IBD2. Wild-type cells (W303) arrested HU  <br /> leased presence 2% galactose induce overexpression IBD2. Cells taken 30 min 210 min, Pds1p Clb2p examined extract immunoblots. shows wild-type cells transformed vector pMW20  shows wild-type cells overexpression IBD2 induced. Pds1p Clb2p stabilized cells <br /> overexpressing IBD2, Pds1p Clb2p wild-type cells degrade cells exit mitosis. loading control, actin blot sample shown. <br />                            IBD2 Encodes Novel Spindle Checkpoint Regulator Budding Yeast                       603 <br />  <br /> mitotic delay response Mps1p overexpression im-        observed bub2&#226;&#338;&#172; cells minor mitotic arrest <br /> plies IBD2 BUB2 likely function       detected bfa1&#226;&#338;&#172;. explained pathway. incomplete mitotic delay            regulator Bub2p Bfa1p interacts sponse Mps1p overexpression ibd2&#226;&#338;&#172; bub2&#226;&#338;&#172;            Ibd2p mitotic arrest. spindle checkpoint suggests IBD2 BUB2 downstream           bifurcated Mad/Bub-dependent Bub2-depen- <br /> MPS1 MPS1 functions effectively        dent pathways, mitotic arrest Ibd2p overexpres- MAD/BUB pathway BUB2-depen-             sion mad2&#226;&#338;&#172; likely functional inde- <br /> dent pathway.                                                pendence IBD2 MAD2 different pathways    Overexpression Ibd2p induces mitotic arrest:       supports hypothesis IBD2 functions BUB2 <br /> function Ibd2p spindle checkpoint      pathway. <br /> verified studying overexpression Ibd2p.          gain insight functional pathway <br /> expression Ibd2p GAL10-1 promoter            Ibd2p, measured level Clb2p wild- <br /> wild-type cells blocked cell cycle mitosis,     type mad1&#226;&#338;&#172;, bfa1&#226;&#338;&#172;, bub2&#226;&#338;&#172; cells overex- <br /> vealed DAPI staining nuclear morphology               pressing Ibd2p. described  overexpression <br /> counts. total 78% wild-type cells overexpressing     IBD2 wild type resulted mitotic arrest  <br /> Ibd2p arrested metaphase anaphase       creased Clb2p (Figure 4A Figure 4, C D).  large bud, 29% wild-type cells      expression Ibd2p resulted increased level vector control M phase (Figure 4A).         Clb2p mad1&#226;&#338;&#172; bfa1&#226;&#338;&#172; bub2&#226;&#338;&#172;, reinforcing <br /> creased mitotic arrest phenotypes Ibd2p overexpres-       conclusion Ibd2p component spindle <br /> sion strongly suggest Ibd2p functions spindle    checkpoint overexpression Ibd2p induces <br /> checkpoint.                                                  mitotic arrest BUB2 pathway upstream    confirm overexpression Ibd2p does          BFA1 BUB2. activate spindle checkpoint indirectly causing       analyzed stability Pds1p wild-type cells spindle defect, inspected microtubule structures        overexpressing Ibd2p verify mitotic arrest cells overexpressing Ibd2p antitubulin immuno-         caused Ibd2p overexpression. experiment, <br /> fluorescence microscopy. seen Figure 4B,        wild-type cells synchronized S phase 0.1 m <br /> cells overexpressing Ibd2p did defect        HU released presence 2% galactose orientation microtubules displayed        induce overexpression IBD2. control cells ex- <br /> mal microtubule patterns M-phase cells metaphase       pressing vector  Pds1p accumulated gradually anaphase. cells arrested mitosis Ibd2p     completely degraded 210 min release <br /> overexpression analyzed spindle        cells exit mitosis. Clb2p, degradation patterns, 67.1% cells short spindle 32.9%       inhibited Pds1p (Cohen-Fix Koshland 1999), <br /> contained elongated spindle (Figure 4B, .       began decrease 90 min Pds1p started observations demonstrated overexpression         diminish (Figure 4E). contrast, cells Ibd2p does generate mitotic spindle defects          overexpression Ibd2p induced, Pds1p accumu- <br /> induces mitotic arrest directly role com-   lated maintained constant high level. Clb2p <br /> ponent spindle checkpoint. mitotic arrest         maintained stably cells (Figure 4E). <br /> caused overexpression Ibd2p wild type       observed stability Pds1p wild-type cells overex- validated measuring Clb2p levels.         pressing Ibd2p confirms overexpression of Clb2p wild-type cells overexpressing Ibd2p         Ibd2p induces mitotic arrest Ibd2p functions <br /> elevated relative actively growing wild-type cells, al-   component spindle checkpoint. similar actin present,           IBD2 belongs BUB2 epistasis group: comparable wild-type cells arrested mitosis    results, including phenotypes ibd2&#226;&#338;&#172; pres- result nocodazole treatment (Figure 4, C D).     ence nocodazole Ibd2p overexpression, <br />    examine bifurcated spindle path-       strongly suggest IBD2 functions BUB2 branch <br /> ways pathway Ibd2p functions, Ibd2p         spindle checkpoint. function IBD2 overexpression phenotypes observed wild-type         BUB2 pathway validated genetic epistasis mad2&#226;&#338;&#172;, bfa1&#226;&#338;&#172;, bub2&#226;&#338;&#172; cells,       analysis. Blockage MAD2 BUB2 pathways compared negative controls strain     mad2&#226;&#338;&#172;bub2&#226;&#338;&#172; double mutant appeared ablate overexpressed vector control. increased         checkpoint completely, cells progressed <br /> mitotic arrest caused Ibd2p overexpression ob-        cell cycle mitotic delay served mad2&#226;&#338;&#172; cells bfa1&#226;&#338;&#172;         rebudded rapidly single mutant (mad2&#226;&#338;&#172; bub2&#226;&#338;&#172; (Figure 4A). compared         bub2&#226;&#338;&#172;) presence nocodazole (Fesquet et <br /> vector control, lack mitotic arrest response    al. 1999). IBD2 functions BUB2 branch, Ibd2p overexpression bfa1&#226;&#338;&#172; bub2&#226;&#338;&#172; suggests        expect checkpoint blocked <br /> Ibd2p functions Bfa1p Bub2p BUB2          effectively ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; mutant pathway. mitotic arrest Ibd2p overexpression       ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172;. constructed ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; strain (YSK2) <br />     Figure 5.&#226;&#8364;&#8221;IBD2 belongs BUB2 epistasis group.   New bud formation ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; presence nocodazole. Logarithmically growing wild-type (W303), ibd2&#226;&#338;&#172; (YSK3), bub2&#226;&#338;&#172; (MAY2052), mad2&#226;&#338;&#172; (RHC15.1), ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; <br /> (YSK5), ibd2&#226;&#338;&#172;bfa1&#226;&#338;&#172; (YSK10), ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; (YSK7) cells incubated presence 15 &#226;?&#174;g/ml nocodazole, cells new buds counted 20 min 160 min fixation brief sonication. total 300 cells counted time point percentage cells new buds time point calculated relative total number cells <br /> counted. independent experiments performed average plotted standard deviations. (B) Cell cycle <br /> progression ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; presence nocodazole analysis DNA content.   ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; <br /> (YSK5), (b) ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; (YSK7), (c) bub2&#226;&#338;&#172; (MAY2052), (d) mad2&#226;&#338;&#172; (RHC15.1) arrested &#226;?&#163;-factor released presence 15 &#226;?&#174;g/ml nocodazole 110 min. Cells taken 10 min DNA contents analyzed flow cytometry described materials methods. (C) dyn1&#226;&#338;&#172;ibd2&#226;&#338;&#172; cells proceed mitosis misoriented <br /> mitotic spindle. dyn1&#226;&#338;&#172; ibd2&#226;&#338;&#172; double mutant constructed phenotypes compared dyn1&#226;&#338;&#172; DAPI antitubulin immunostaining. number cells phenotype counted shown table. images,  dyn1&#226;&#338;&#172; single mutant;  dyn1&#226;&#338;&#172;ibd2&#226;&#338;&#172; double mutant. DAPI staining DNA (left) antitubulin staining (right) shown. scale panels. Bar, 5 &#226;?&#174;m. <br />                            IBD2 Encodes Novel Spindle Checkpoint Regulator Budding Yeast                             605 <br />  <br />                                                                  double mutant especially remarkable                                                                  early stages incubation nocodazole (Figure 5A). <br />                                                                     examined mitotic arrest defect cell <br />                                                                  cycle progression ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172;                                                                  measuring DNA content. cell cycle progression <br />                                                                  bub2&#226;&#338;&#172; mad2&#226;&#338;&#172; single mutants wild type <br />                                                                  monitored controls. experiment, ibd2&#226;&#338;&#172;- <br />                                                                  bub2&#226;&#338;&#172;, ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172;, bub2&#226;&#338;&#172;, mad2&#226;&#338;&#172; cells log phase <br />                                                                  arrested &#226;?&#163;-factor released presence <br />                                                                  15 &#226;?&#174;g/ml nocodazole 110 min, DNA <br />                                                                  content analyzed 10 min flow cytometry. <br />                                                                  Approximately 80% wild-type mutant cells <br />                                                                  arrested G1 &#226;?&#163;-factor 1N DNA content. <br />                                                                  Wild-type cells gradually arrested 2N DNA <br />                                                                  content presence nocodazole cells reached <br />                                                                  mitosis (Figure 3C data shown). Similarly,                                                                  ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; double mutants pro- <br />                                                                  ceeded cell cycle displayed 2N DNA <br />                                                                  content release.  shown Figure 5B, <br />                                                                  b, fraction ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; cells began display <br />                                                                  4N DNA content 80 min release                                                                  proportion highly increased 110 min                                                                  noticeable mitotic delay. Conversely, ibd2&#226;&#338;&#172;- <br />                                                                  bub2&#226;&#338;&#172; cells retained 2N DNA content 80 min   Figure 5.&#226;&#8364;&#8221;Continued.                                           small portion cells 4N DNA content <br />                                                                  started appear 110 min, suggesting temporal <br />                                                                  mitotic delay double mutant presence ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; strain (YSK3) investigated                 nocodazole (Figure 5B, . ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172;, bub2&#226;&#338;&#172; increased nocodazole sensitivity detected            mad2&#226;&#338;&#172; single mutant cells showed temporal mi- enhanced checkpoint defect double mu-              totic delay 2N DNA content 90 min tant.  counted rebudding double            small portion cells began 4N DNA <br /> mutants presence nocodazole, cells          content 110 min (Figure 5B, c d).  <br /> released arrest &#226;?&#163;-factor. seen          deletion IBD2 MAD2 appeared ablate <br /> Figure 5A, proportion cells new buds           spindle checkpoint severely IBD2 ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; double mutant similar           BUB2, suggesting IBD2 MAD2 function bub2&#226;&#338;&#172; single mutant, increase occurred little          separate checkpoint pathways IBD2 BUB2 rapidly ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172; comparison ibd2&#226;&#338;&#172;,             likely belong epistasis group. <br /> mad2&#226;&#338;&#172;, ibd2&#226;&#338;&#172;bub2&#226;&#338;&#172; mutants. Cell cycle progression               BUB2 checkpoint pathway reported assayed new bud formation ibd2&#226;&#338;&#172;mad2&#226;&#338;&#172;                monitor anaphase spindle position. BUB2 required <br />  <br />  <br />                                                             TABLE 2 <br />                                             MPS1 overexpression ibd2&#226;&#338;&#172; cells <br />  <br />         Overexpression                       M arrest (%)                 Multibud (%)                 Normal (%) <br />         WT &#226;&#171;&#185; MPS1                             75.5   &#226;&#171;&#190;   1.5               17.0   &#226;&#171;&#190;   1.5               7.5   &#226;&#171;&#190;   1.5 <br />         WT &#226;&#171;&#185; pRS316                      19.0   &#226;&#171;&#190;   0.5                2.5   &#226;&#171;&#190;   0.5              78.5   &#226;&#171;&#190;   0.5 <br />         ibd2&#226;&#338;&#172; &#226;&#171;&#185; MPS1                            54   &#226;&#171;&#190;   0.5                 39   &#226;&#171;&#190;   0.5                 7   &#226;&#171;&#190;   0.5 <br />         ibd2&#226;&#338;&#172; &#226;&#171;&#185; pRS316                   22.5   &#226;&#171;&#190;   1.5               24.5   &#226;&#171;&#190;   1.5              52.0   &#226;&#171;&#190;   1.5 <br />         bub2&#226;&#338;&#172; &#226;&#171;&#185; MPS1                            56   &#226;&#171;&#190;   3.5                 40   &#226;&#171;&#190;   3.5                 4   &#226;&#171;&#190;   3.5 <br />         bub2&#226;&#338;&#172; &#226;&#171;&#185; pRS316                   17.5   &#226;&#171;&#190;   0.5               22.0   &#226;&#171;&#190;   0.5              60.5   &#226;&#171;&#190;   0.5 <br />         mad2&#226;&#338;&#172; &#226;&#171;&#185; MPS1                          29.5   &#226;&#171;&#190;   1.06                64   &#226;&#171;&#190;   1.06              6.5   &#226;&#171;&#190;   1.06 <br />         mad2&#226;&#338;&#172; &#226;&#171;&#185; pRS316                   25.5   &#226;&#171;&#190;   1.5               27.0   &#226;&#171;&#190;   1.5              47.5   &#226;&#171;&#190;   1.5 <br />           MPS1 overexpressed wild-type (W303), ibd2&#226;&#338;&#172; (YSK3), bub2&#226;&#338;&#172; (MAY2052), mad2&#226;&#338;&#172; (RHC15.1) cells <br />         2% galactose 12 hr 29&#226;&#172;&#353;. Cells fixed 70% EtOH, sonicated briefly, phenotypes         examined staining DAPI. total 300 cells counted sample; average         independent experiments presented. <br />  606                                               H.-S. Hwang K. Song <br />  <br />                           TABLE 3                                                          TABLE 4 <br />    Rescue mitotic arrest defects ibd2&#226;&#338;&#172;        Rescue mitotic arrest defects spindle checkpoint <br />                  spindle checkpoint genes                                              mutants IBD2 <br />  <br /> Rescue                     M arrest (%)       Multibud (%)       Rescue                      M arrest (%)       Multibud (%) <br /> WT                         87.2   &#226;&#171;&#190;   2.5      12.8   &#226;&#171;&#190;   2.5    bub2&#226;&#338;&#172; &#226;&#171;&#185; BFA1                   58   &#226;&#171;&#190;   2.5       42   &#226;&#171;&#190;   2.5 <br /> ibd2&#226;&#338;&#172;                      18.4   &#226;&#171;&#190;   1.5      81.6   &#226;&#171;&#190;   1.5    bub2&#226;&#338;&#172; &#226;&#171;&#185; IBD2                 46.8   &#226;&#171;&#190;   2.5     53.2   &#226;&#171;&#190;   2.5 <br /> ibd2&#226;&#338;&#172;   &#226;&#171;&#185;   IBD2           74.5   &#226;&#171;&#190;   1.06     25.5   &#226;&#171;&#190;   1.06   bub2&#226;&#338;&#172; &#226;&#171;&#185; BUB2                 83.7   &#226;&#171;&#190;   1.5     16.3   &#226;&#171;&#190;   1.5 <br /> ibd2&#226;&#338;&#172;   &#226;&#171;&#185;   BFA1           74.9   &#226;&#171;&#190;   2.5      25.1   &#226;&#171;&#190;   2.5    bub2&#226;&#338;&#172; &#226;&#171;&#185; pRS315            17   &#226;&#171;&#190;   0.5       83   &#226;&#171;&#190;   0.5 <br /> ibd2&#226;&#338;&#172;   &#226;&#171;&#185;   BUB2           73.2   &#226;&#171;&#190;   1.06     26.8   &#226;&#171;&#190;   1.06   bfa1&#226;&#338;&#172; &#226;&#171;&#185; BFA1                   79   &#226;&#171;&#190;   0.5       21   &#226;&#171;&#190;   0.5 <br /> ibd2&#226;&#338;&#172;   &#226;&#171;&#185;   MAD2           39.5   &#226;&#171;&#190;   3.5      60.5   &#226;&#171;&#190;   3.5    bfa1&#226;&#338;&#172; &#226;&#171;&#185; IBD2                   22   &#226;&#171;&#190;   1.5       78   &#226;&#171;&#190;   1.5 <br /> ibd2&#226;&#338;&#172;   &#226;&#171;&#185;   CDC5           72.8   &#226;&#171;&#190;   2.5      27.2   &#226;&#171;&#190;   2.5    bfa1&#226;&#338;&#172; &#226;&#171;&#185; BUB2                 73.7   &#226;&#171;&#190;   1.06    26.3   &#226;&#171;&#190;   1.06 <br /> ibd2&#226;&#338;&#172;   &#226;&#171;&#185;   pRS316    19.6   &#226;&#171;&#190;   1.5      80.4   &#226;&#171;&#190;   1.5    bfa1&#226;&#338;&#172; &#226;&#171;&#185; pRS316          19.3   &#226;&#171;&#190;   0.5     80.7   &#226;&#171;&#190;   0.5 <br />                                                                  mad2&#226;&#338;&#172; &#226;&#171;&#185; IBD2                 39.5   &#226;&#171;&#190;   1.5     60.5   &#226;&#171;&#190;   1.5 <br />   ibd2&#226;&#338;&#172; (YSK3) cells transformed pRS316/IBD2,          mad2&#226;&#338;&#172; &#226;&#171;&#185; pRS316          21.5   &#226;&#171;&#190;   2.5     78.5   &#226;&#171;&#190;   2.5 <br /> BFA1, BUB2, MAD2, CDC5 endogenous <br /> promoters, incubated presence nocodazole 3 hr,       bfa1&#226;&#338;&#172; (YSK8), bub2&#226;&#338;&#172; (MAY2052), mad2&#226;&#338;&#172; (RHC15.1) counted according phenotypes fixation      cells transformed pRS316/IBD2, incubated pres- <br /> 70% EtOH DAPI staining. total 300 fixed cells      ence nocodazole 3 hr, counted according counted sample; average independent        phenotypes fixation 70% EtOH staining experiments presented.                                        DAPI. total 300 fixed cells counted sample; <br />                                                                  average independent experiments presented. <br />  prevention spindle breakdown mitotic <br /> exit yeast cells lacking dynein dynactin,         suggests IBD2 functions upstream BFA1 poles spindle mother cell                 BUB2 BUB2 pathway. address (Bloecher et al. 2000).  &#226;&#181;&#8216;25% bub2&#226;&#338;&#172;-            IBD2 functions BUB2 spindle checkpoint pathway, <br /> dyn1&#226;&#338;&#172; double mutant cells misaligned spindles               investigated loss mitotic arrest completed anaphase initiated new bud formation,              ibd2&#226;&#338;&#172; presence microtubule-destabilizing 95% dyn1&#226;&#338;&#172; mutant cells misaligned              drugs compensated extra copies BFA1 <br /> spindles arrested mitosis (Bloecher et al. 2000).        BUB2 CEN plasmid, summarized Table IBD2 functions BUB2 pathway, ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172;           3. examined presence IBD2 cells expected undergo nuclear division         CEN plasmid suppress lack mitotic arrest mother enter cell cycle,           bfa1&#226;&#338;&#172; bub2&#226;&#338;&#172; exposure nocodazole (Table <br /> observed bub2&#226;&#338;&#172;dyn1&#226;&#338;&#172;. confirm IBD2 func-              4). total 82% negative controls (ibd2&#226;&#338;&#172; cells trans- <br /> tions BUB2 branch spindle checkpoint               formed CEN plasmid pRS316  failed pathway, constructed ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172; double mutant               undergo mitotic arrest presence nocodazole, compared progression mitosis ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172;            75% positive controls (ibd2&#226;&#338;&#172; cells transformed dyn1&#226;&#338;&#172;. Consistent previous reports          IBD2 CEN plasmid) able restore mitotic <br /> dyn1&#226;&#338;&#172; (Li et al. 1993; Bloecher et al. 2000), 9%            arrest. compared ibd2&#226;&#338;&#172; mad2&#226;&#338;&#172; cells dyn1&#226;&#338;&#172; single mutant cells contained misaligned           transformed pRS316  mitotic arrest  <br /> anaphase spindles exited mitosis formed extra             fects ibd2&#226;&#338;&#172; improved presence <br /> bud. hand, 38% ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172; double                 MAD2 vice versa (Tables 3 4), supporting <br /> mutant cells gave rise binuclear mother cells             idea IBD2 MAD2 pathway. Extra <br /> anucleate cells contained extra bud (Fig-           copies BUB2 BFA1 able restore <br /> ure 5C). ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172; double mutant cells showed              mitotic arrest &#226;&#181;&#8216;73&#226;&#8364;&#8220;75% ibd2&#226;&#338;&#172; cells, level compa- sharp decrease viability compared single          rable IBD2 itself (Table 3). contrast, mutant, possibly progression cell cycle         BFA1 BUB2 able compensate absence proper nuclear division, case           inability bfa1&#226;&#338;&#172; bub2&#226;&#338;&#172; cells undergo mitotic bub2&#226;&#338;&#172;dyn1&#226;&#338;&#172; (data shown). ibd2&#226;&#338;&#172;dyn1&#226;&#338;&#172;                 arrest, extra copies IBD2 (Table 3). phenotypes similar reported bub2&#226;&#338;&#172;-         genetic interactions IBD2 consistent data <br /> dyn1&#226;&#338;&#172; strongly suggest IBD2 belongs              described previously indicating IBD2 functions  <br /> BUB2 epistasis group functions BUB2-depen-            stream BUB2 BFA1 BUB2-dependent spin- <br /> dent spindle checkpoint.                                         dle checkpoint pathway. Interestingly, extra copy    Mitotic arrest defects &#226;&#338;&#172;ibd2 rescued             CDC5, encodes polo-like kinase functioning extra copies BUB2 BFA1: described                mitotic exit cytokinesis, rescue deficiency lack mitotic arrest Ibd2p overexpression            mitotic arrest ibd2&#226;&#338;&#172; (Song Lee 2001). bfa1&#226;&#338;&#172; bub2&#226;&#338;&#172; similar Mps1p overexpres-         hard define relationship IBD2 CDC5 <br /> sion phenotypes observed ibd2&#226;&#338;&#172; bub2&#226;&#338;&#172; mutants              solely basis result, suggests <br />                             IBD2 Encodes Novel Spindle Checkpoint Regulator Budding Yeast                        607 <br />  possible genetic interaction genes        observed Ibd2p overexpression caused link checkpoint function IBD2          M-phase arrest short bipolar spindle <br /> mitotic exit.                                                 (67.1%) elongated bipolar anaphase B spindle <br />                                                               (32.9%), overexpression Bfa1p reported <br />                                                               Li (1999) induce cell cycle arrest mainly                       DISCUSSION <br />                                                               elongated anaphase B spindle. reported pre- <br />     IBD2 new component BUB2-dependent             viously MPS1 functions upstream MAD- <br /> spindle checkpoint budding yeast: Bfa1p, Bub2p,        BUB-dependent spindle checkpoints Tem1p associated spindle pole body (SPB)         overexpression leads cell cycle arrest predominantly budding yeast comprise Bub2p-             short bipolar spindles (Hardwick et al. 1996). <br /> dependent spindle checkpoint (Alexandru et al. 1999;          Pds1p shown control initiation ana- <br /> Li 1999). homologies Bfa1p Bub2p              phase mitotic exit interact mitotic exit budding yeast Byr4p Cdc16p fission yeast        network (MEN) proteins unknown mechanisms <br /> suggest Bfa1p Bub2p form compo-          (Cohen-Fix Koshland 1999; Tinker-Kulberg <br /> nent GAP SPB inhibits Tem1p GTPase,           Morgan 1999). observation overex- blocking mitotic exit (Furge et al. 1998). Recent        pression Ibd2p caused M-phase arrest reports suggest new model inhibition        short bipolar spindle elongated bipolar <br /> Tem1p Bfa1p/Bub2p GAP molecular switch           anaphase B spindle suggests possibility commu- <br /> acts Bub2p-dependent spindle checkpoint             nication Pds1p Ibd2p occur upstream <br /> prevent spindle breakdown, nuclear division, cytoki-      Bfa1p Bub2p defects spindle <br /> nesis response failure nuclear migration      formation orientation. bud, typically results spindle orientation        results mitotic arrest caused Ibd2p <br /> defects (Bardin et al. 2000; Bloecher et al. 2000;        overexpression observed bub2&#226;&#338;&#172; bfa1/ <br /> eira et al. 2000). model, divided nucleus    ibd1&#226;&#338;&#172;, mitotic arrest defects ibd2&#226;&#338;&#172; progeny SPB migrate new bud, Lte1p,              presence nocodazole restored additional <br /> <span id='am-21' about='obo:IMR_0200319' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-22' property="oboInOwl:hasDbXref" content="KEGG:C00242" datatype="xsd:string"></span><span id='am-23' property="rdfs:label" content="Guanine" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:id" content="IMR:0200319" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>guanine</span> <span id='am-8' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-9' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-11' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span><span id='am-13' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>nucleotide</span> exchange factor (GEF) pres-        copies BUB2 BFA1 extra copy IBD2 <br /> ent bud, activates Tem1p GTPase            rescue mitotic arrest defects bub2&#226;&#338;&#172; <br /> stimulate mitotic exit cytokinesis (Bardin et al.         bfa1&#226;&#338;&#172;, consistent model IBD2 <br /> 2000; Pereira et al. 2000). interactions Bim1p         functions upstream BUB2 BFA1. Considering Kar9p cortical sites reported           Ibd2p Bfa1p directly interact extra copy <br /> properly orient mitotic spindle yeast (Korinek         BFA1 BUB2 rescues mitotic defect et al. 2000; Lee et al. 2000; Miller et al. 2000).    ibd2&#226;&#338;&#172;, expect Ibd2p, Bfa1p, Bub2 remains answered Bfa1p Bub2p       form complex transmit spindle orientation  sufficient act molecular switch      fect block mitotic exit. observed Ibd2p physi- spindle orientation defects transmitted            cally interacts Bfa1p does interact directly <br /> Bfa1p/Bub2p.                                                  Bub2p (H. Hwang, unpublished data),     isolated novel Bfa1p interacting protein        Ibd2p Bub2p communicate Bfa1p <br /> named Ibd2p. presented evidence IBD2             forming complex  observation functions component spindle checkpoint         Ibd2p localized dot near nuclear periphery BUB2-dependent branch pathway upstream            expressed green fluorescent protein (GFP) Bfa1p Bub2p. IBD2 deletion mutants proceeded           fusion multicopy plasmid suggests endogenous cell cycle presence microtubule-        Ibd2p, like Bfa1p, localized spindle pole body <br /> destabilizing drugs, causing sharp decrease      supports possibility form complex viability. IBD2 overexpression induced mitotic arrest      spindle pole body (H. Hwang, unpublished data). <br /> wild-type cells, verified increased levels Clb2p        observed mitotic arrest defect stabilization Pds1p, pattern micro-     ibd2&#226;&#338;&#172; presence nocodazole restored tubule structures normal cells. mitotic     additional copies CDC5. CDC5 encodes polo-like <br /> arrest response IBD2 overexpression ob-         kinase S. cerevisiae functions component served BUB2 slightly detected BFA1 dele-        MEN, CDC5 participates mitotic exit <br /> tion mutant cells. results strongly suggest        pathway known (Kitada et al. 1993; Jaspersen et <br /> IBD2 functions component spindle check-           al. 1998). Cdc5p plays role regulating cytokine- <br /> point pathway upstream BUB2 BFA1. minor            sis proposed coordinate mitotic exit cytoki- <br /> difference Ibd2p overexpression phenotypes BUB2         nesis (Song Lee 2001). recent report showed BFA1 deletion mutants explained regu-       phosphorylation Bfa1 Cdc5p regulates <br /> lator Bub2p Bfa1p interacts Ibd2p          checkpoint function Bfa1p (Hu et al. 2001). mitotic arrest. study proteins interacting     data showing mitotic arrest defect ibd2&#226;&#338;&#172; Ibd2p answer possibility. Interestingly,      rescued additional copies CDC5 suggest IBD2 <br />  608                                                       H.-S. Hwang K. Song <br />  likely function upstream CDC5 mitotic                    University English editing. work supported grant <br />                                                                          Korean Ministry Science Technology (Critical Tech- <br /> exit pathway regulate function Bfa1p.  <br />                                                                          nology 21 &#226;&#8364;&#339;Life Phenomena Function Research&#226;&#8364;?; 00-J-LF-01- genetic interaction IBD2 CDC5                      B-60) donated K. Song partly grant Korean confined control mitotic exit,                 Science <span id='am-1' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-2' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-6' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-7' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span>amp</span>; Engineering Foundation (KOSEF 1999-2-207-003-3). <br /> deletion overexpression IBD2 does affect cyto- <br /> kinesis. <br />    Possible functions IBD2 BUB2-dependent <br />                                                                                               LITERATURE CITED <br /> pathway: Ibd2p component Bub2- <br /> dependent spindle checkpoint identified acts                  Alexandru, G., W. Zacharie,  Schleiffer K. Nasmyth, 1999 <br />                                                                              Sister chromatid separation chromosome duplication directly upstream Bfa1p Bub2p. Bub2p-                       regulated different mechanisms response spindle dam- <br /> dependent spindle checkpoint prevents mitotic exit                       age. EMBO J. 18: 2707&#226;&#8364;&#8220;2721. <br /> cytokinesis response spindle orientation defects,                  Bardin, , J. R. Vistin  Amon, 2000 mechanism cou- <br />                                                                              pling exit mitosis partitioning nucleus. Cell 102: <br /> Ibd2p likely function transmitting signals                    21&#226;&#8364;&#8220;31. <br /> spindle integrity Bfa1p Bub2p regulating                      Berlin, V., C.  Styles G. Fink, 1990 Bik1, protein required exit mitosis. Ibd2p novel protein                      microtubule function mating mitosis Saccharo- <br />                                                                              myces cerevisiae, colocalizes tubulin. J. Cell Biol. 111: 2573&#226;&#8364;&#8220; <br /> homology proteins known function, contains                      2586. conserved sequence (CCPHHHYENLS) chi-                         Bloecher, , G. M. Venturi K. Tatchell, 2000 Anaphase <br /> tinase families (Huang Brutlag 2001). motif                         spindle position monitored BUB2 checkpoint. Nat. Cell <br />                                                                              Biol. 2: 556&#226;&#8364;&#8220;558. Bik1p, required proper                     Cahill, D. P., C. Lengauer, J. Yu, G. J. Riggins, J. K. Willson et al., <br /> microtubule function mitosis shows                          1998 Mutations mitotic checkpoint genes human cancers. genetic direct physical interactions Bim1p                     Nature 392: 300&#226;&#8364;&#8220;303. <br />                                                                          Chen, R. H., J. C. Waters, E. D. Salmon  W. Murray, 1996 &#226;?&#163;-tubulin budding yeast (Berlin et al. 1990;                          Association spindle assembly checkpoint component XMAD2 <br /> Schwartz et al. 1997). conservation se-                          unattached kinetochores. Science 274: 242&#226;&#8364;&#8220;246. <br /> quence Ibd2p points possible functions                    Chen, R. H.,  Shevchenko, M. Mann  W. Murray, 1998 <br />                                                                              Spindle checkpoint protein xmad1 recruits xmad2 unattached Ibd2p monitoring spindle orientation defects dur-                      kinetochores. J. Cell Biol. 143: 283&#226;&#8364;&#8220;295. <br /> ing mitosis. unpublished data suggest                    Cohen-Fix, O., D. Koshland, 1999 Pds1p budding yeast main Ibd2p containing motif important                         dual roles: inhibition anaphase initiation regulation                                                                              mitotic exit. Genes Dev. 13: 1950&#226;&#8364;&#8220;1959. <br /> eliciting mitotic arrest observed overexpres-                   Duenas, E., J. L. Revuelta, F. Del Rey C. R. Vazquez Aldana, <br /> sion Ibd2p. analysis genetic physical                      1999 Disruption basic phenotype analysis novel genes <br /> interactions Ibd2p proteins involved                          left arm chromosome XIV Saccharomyces cerevisiae. <br />                                                                              Yeast 15: 63&#226;&#8364;&#8220;72. <br /> proper spindle orientation Bim1p, Kar9p, Bik1p,                  Fang, G., H. Yu M. W. Kirschner, 1998 checkpoint protein Nud1p underway clues                            MAD2 mitotic regulator CDC20 form ternary complex precise mechanism Ibd2p functions                        anaphase-promoting complex control anaphase transi- <br />                                                                              tion. Genes Dev. 12: 1871&#226;&#8364;&#8220;1883. <br /> spindle checkpoint.                                                      Fesquet, D., P. J. Fitzpatrick,  L. Johnson, K. M. Kramer, J. H. <br />    overexpression Ibd2p induced mitotic                         Toyn et al., 1999 Bub2p-dependent spindle checkpoint path- <br /> arrest upstream Bfa1p Bub2p, Ibd2p act                          way regulates Dbf2 kinase budding yeast. EMBO J. 18: <br />                                                                              2424&#226;&#8364;&#8220;2434. negative regulator Tem1 GTPase, possibly                      Fraschini, R., E. Formenti, G. Lucchini S. Piatti, 1999 Bud- <br /> activating Bfa1 Bub2 GAP inhibiting GEF                        ding yeast Bub2 localized spindle pole bodies activates <br /> Lte1. observed Ibd2p does physically inter-                      mitotic checkpoint different pathway Mad2. J. Cell <br />                                                                              Biol. 145: 979&#226;&#8364;&#8220;991. <br /> act Lte1p localized dot near nuclear                Furge, K. , K. Wong, J. Amstrong, M. Balasubramanian periphery expressed GFP fusion, suggesting                         C. F. Albright, 1998 Byr4 Cdc16 form component localizes spindle pole body, does Bfa1p                    GTPase-activating protein Spg1 GTPase controls sep- <br />                                                                              tation fission yeast. Curr. Biol. 8: 947&#226;&#8364;&#8220;954. <br /> (H. Hwang, unpublished data). observations                         Gyuris, J., E. Golemis, H. Chertkov R. Brent, 1993 Cdi1, strongly suggest Ibd2p functions negatively                          human G1 S phase protein phosphatase associates Tem1 GTPase direct interaction Bfa1p. Al-                            Cdk2. Cell 75: 791&#226;&#8364;&#8220;803. <br />                                                                          Hardwick, K. G., E. Weiss, F. C. Luca, M. Winey  W. Murray, direct interaction Ibd2p                          1996 Activation budding yeast spindle assembly check- Lte1p, genome-wide hybrid analysis reported                        point mitotic spindle disruption. Science 273: 953&#226;&#8364;&#8220;956. Ibd2p connected Lte1p YNL091W                         Hoyt, M. , L. Totis B. T. Roberts, 1991 S. cerevisiae genes <br />                                                                              required cell cycle arrest response loss microtubule Msl1p (Uetz et al. 2000).  possibility                     function. Cell 66: 507&#226;&#8364;&#8220;517. Ibd2p acts negatively influence Lte1p                  Hu, F., Y. Wang, D. Liu, Y. Li, J. Qin et al., 2001 Regulation excluded. Conceivably, Ibd2p function indirectly                       Bub2/Bfa1 GAP complex Cdc5 cell cycle checkpoint. Cell <br />                                                                              107: 655&#226;&#8364;&#8220;665. inactivate Tem1p GTPase activating Bfa1p                      Huang, J. Y., D. L. Brutlag, 2001 eMOTIF database. inactivating Lte1p block mitotic exit                         Nucleic Acids Res. 29: 202&#226;&#8364;&#8220;204. defects spindle formation orientation.                  Hwang, L. H., L. Lau, D. Smith, C.  Mistrot K. G. Hardwick, <br />                                                                              1998 Budding yeast Cdc20: target spindle checkpoint. <br />   thank Drs. J. Kim, K. Choi, M. Winey, C. Rodriquez, F. Galibert,        Science 279: 1041&#226;&#8364;&#8220;1044.  Hoyt,  Toh-e, M. Lonetine, F. Rey providing yeast strains   Jaspersen, S. L., J. F. Charles, R. L. Tinker-Kulberg D. O. plasmids. indebted Dr. Kris Gunsalus New York          Morgan, 1998 late mitotic regulatory network controlling <br />                                  IBD2 Encodes Novel Spindle Checkpoint Regulator Budding Yeast                                         609 <br />      cyclin destruction Saccharomyces cerevisiae. Mol. Biol. Cell 9:   Pereira, G., T. Hofken, J. Grindlay, C. Manson E. Schiebel, <br />      2803&#226;&#8364;&#8220;2817.                                                               2000 Bub2p spindle checkpoint links nuclear migration <br /> Jwa, M., K. Song, 1998 Byr4, dosage-dependent regulator              mitotic exit. Mol. Cell 6: 1&#226;&#8364;&#8220;10. <br />      cytokinesis S. pombe, interacts possible small GTPase      Schwab, M.,  S. Lutum W. Seufert, 1997 Yeast Hct1      pathway including Spg1 Cdc16. Mol. Cell 8: 240&#226;&#8364;&#8220;245.                  regulator Clb2 cyclin proteolysis. Cell 90: 683&#226;&#8364;&#8220;693. <br /> Kitada, K.,  L. Johnson, L. H. Johnston  Sugino, 1993             Schwartz, K., K. Richards D. Botstein, 1997 BIM1 encodes <br />      multicopy suppressor gene Saccharomyces cerevisiae G1           microtubule-binding protein yeast. Mol. Biol. Cell 8: 2677&#226;&#8364;&#8220; <br />      cell cycle mutant gene dbf4 encodes protein kinase              2691. <br />      identified CDC5. Mol. Cell. Biol. 13: 4445&#226;&#8364;&#8220;4457.                  Sena, P., D. N. Radin S. Fogel, 1973 Synchronous mating Korinek, W. S., M. J. Copeland,  Chaudhuri J. Chant, 2000               yeast. Proc. Natl. Acad. Sci. USA 70: 1373&#226;&#8364;&#8220;1377. <br />      Molecular linkage underlying microtubule orientation          Shirayama, M.,  Toth, M. Galova K. Nasmyth, 1999 APC <br />      cortical sites yeast. Science 287: 2257&#226;&#8364;&#8220;2259.                         (Cdc20) promotes exit mitosis destroying anaphase <br /> Lee, J., H.-S. Hwang, J. Kim K. Song, 1999 Ibd1p, possible              inhibitor Pds1 cyclin Clb5. Nature 402: 203&#226;&#8364;&#8220;207. <br />      spindle pole body associated protein, regulates nuclear division     Straight,  F.,  W. Murray, 1997 spindle assembly <br />      bud sepa <br /> </body></html>